XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net loss $ (14,479,000) $ (20,525,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 1,287,000 2,093,000
Amortization of financing issuance costs 281,000 0
Depreciation and amortization 132,000 144,000
Other 131,000 (139,000)
Changes in operating assets and liabilities:    
Accounts receivable (140,000) (301,000)
Prepaid expenses and other assets 762,000 (944,000)
Accounts payable (810,000) 661,000
Accrued and other liabilities (2,412,000) 28,000
Net cash used in operating activities (15,248,000) (18,983,000)
Cash flows from investing activities:    
Maturities of short-term investments 2,000,000 39,000,000
Proceeds from sale of property and equipment 1,000 0
Purchases of short-term investments 0 (28,726,000)
Purchases of property and equipment 0 (69,000)
Net cash provided by investing activities 2,001,000 10,205,000
Cash flows from financing activities:    
Proceeds from the sale of common stock and warrants 19,754,000 426,000
Payment of issuance costs associated with the sale of common stock (1,193,000) (13,000)
Proceeds from issuance of notes payable 1,726,000 0
Payments of principal on notes payable (1,333,000) (333,000)
Proceeds from stock purchases under employee stock purchase plan 16,000 84,000
Proceeds from the exercise of stock options 13,000 15,000
Net cash provided by financing activities 18,983,000 179,000
Net increase (decrease) in cash and cash equivalents 5,736,000 (8,599,000)
Cash and cash equivalents at beginning of period 24,846,000 32,606,000
Cash and cash equivalents at end of period 30,582,000 24,007,000
Supplemental disclosure of cash flow information    
Cash paid for interest 145,000 277,000
Supplemental disclosure of non-cash investing and financing activities    
Amortization of public offering costs 30,000 1,000
Unpaid common stock issuance costs included in current liabilities 19,000 0
Change in unrealized gain on investments $ 0 $ 14,000